Free Trial
NASDAQ:MDWD

MediWound (MDWD) Stock Price, News & Analysis

MediWound logo
$19.47 +0.35 (+1.83%)
Closing price 07/3/2025 03:05 PM Eastern
Extended Trading
$19.32 -0.15 (-0.77%)
As of 07/3/2025 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About MediWound Stock (NASDAQ:MDWD)

Key Stats

Today's Range
$19.20
$19.47
50-Day Range
$17.25
$22.24
52-Week Range
$14.14
$24.00
Volume
10,185 shs
Average Volume
86,194 shs
Market Capitalization
$210.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$31.80
Consensus Rating
Buy

Company Overview

MediWound Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
37th Percentile Overall Score

MDWD MarketRank™: 

MediWound scored higher than 37% of companies evaluated by MarketBeat, and ranked 2107th out of 2,814 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    MediWound has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    MediWound has only been the subject of 3 research reports in the past 90 days.

  • Read more about MediWound's stock forecast and price target.
  • Earnings Growth

    Earnings for MediWound are expected to grow in the coming year, from ($2.66) to ($2.24) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of MediWound is -9.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of MediWound is -9.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    MediWound has a P/B Ratio of 6.74. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about MediWound's valuation and earnings.
  • Percentage of Shares Shorted

    12.32% of the float of MediWound has been sold short.
  • Short Interest Ratio / Days to Cover

    MediWound has a short interest ratio ("days to cover") of 13, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in MediWound has recently decreased by 3.91%, indicating that investor sentiment is improving.
  • Dividend Yield

    MediWound does not currently pay a dividend.

  • Dividend Growth

    MediWound does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    12.32% of the float of MediWound has been sold short.
  • Short Interest Ratio / Days to Cover

    MediWound has a short interest ratio ("days to cover") of 13, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in MediWound has recently decreased by 3.91%, indicating that investor sentiment is improving.
  • News Sentiment

    MediWound has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for MediWound this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, MediWound insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 9.20% of the stock of MediWound is held by insiders.

  • Percentage Held by Institutions

    46.83% of the stock of MediWound is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about MediWound's insider trading history.
Receive MDWD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MediWound and its competitors with MarketBeat's FREE daily newsletter.

MDWD Stock News Headlines

The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
See More Headlines

MDWD Stock Analysis - Frequently Asked Questions

MediWound's stock was trading at $17.80 at the start of the year. Since then, MDWD stock has increased by 9.4% and is now trading at $19.47.

MediWound Ltd. (NASDAQ:MDWD) posted its quarterly earnings data on Wednesday, May, 21st. The biopharmaceutical company reported ($0.07) EPS for the quarter, topping the consensus estimate of ($0.65) by $0.58. The biopharmaceutical company had revenue of $3.96 million for the quarter, compared to analyst estimates of $5.20 million. MediWound had a negative trailing twelve-month return on equity of 74.12% and a negative net margin of 110.45%.
Read the conference call transcript
.

MediWound's stock reverse split on the morning of Tuesday, December 20th 2022.The 1-7 reverse split was announced on Tuesday, December 20th 2022. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, December 20th 2022. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split.

Shares of MDWD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MediWound investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Adobe (ADBE), ServiceNow (NOW) and Palo Alto Networks (PANW).

Company Calendar

Last Earnings
5/21/2025
Today
7/04/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:MDWD
Employees
80
Year Founded
2001

Price Target and Rating

Average Stock Price Target
$31.80
High Stock Price Target
$39.00
Low Stock Price Target
$25.00
Potential Upside/Downside
+63.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$30.22 million
Net Margins
-110.45%
Pretax Margin
-110.23%

Debt

Sales & Book Value

Annual Sales
$19.21 million
Price / Cash Flow
N/A
Book Value
$2.89 per share
Price / Book
6.74

Miscellaneous

Free Float
9,814,000
Market Cap
$210.43 million
Optionable
Optionable
Beta
0.32

Social Links

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:MDWD) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners